National Human Genome Research Institute (NHGRI) a subsidiary of National Institutes of Health is a research institute that provides human genome researches. The institute offers research programs and projects such as functional analysis program, genome technology program, clinical sequencing exploratory research, and others. It also provides funding services to the division of genome sciences, genome medicine; and genomics and society. NHGRI offers genome variation program, gene tissue expression project, human microbiome project, genome sequencing program, and molecular libraries program. The institute operates in the areas of genome sciences, genome medicine, genomics and society, and others. NHGRI is headquartered in Bethesda, Maryland, the US.
National Human Genome Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Nutrigenomics Market Research Report by Product (Reagents & Kits and Services), by Application (Cancer, Cardiovascular Diseases, and Obesity) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY,...
Plant Genomics Market Research Report by Objective (DNA Extraction & Purification, DNA/Rna Sequencing, GMO-Trait Purity Testing, Gene Expression Profiling, and Genotyping), by Type (Genetic Engineering and Molecular Engineering), by Trait, by Crops - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Genome Engineering Market Research Report by Technology (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease), by Application (Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering), by End-User - Global Forecast to 2025 - Cumulative...
Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...
Global Genomic Data Analysis and Interpretation Market to Reach $2.10 Billion by 2030 Market Report Coverage - Genomic Data Analysis and Interpretation Market Segmentation • Product – Software and Services (License and Maintenance) • Genomic Platform – Next-Generation Sequencing (NGS),...
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing...
The Global Genomics Partnering Terms and Agreements 2014 to 2020 report provides an understanding and access to the Genomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
300 pages •
By The Business Research Company
• Nov 2020
Oligonucleotide Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global oligonucleotide therapy market. This report focuses on oligonucleotide therapy market which is experiencing strong growth. The report...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.